Lameditech Co., Ltd. (462510) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lameditech Co., Ltd. (462510:KRX), powered by AI.

Current Price
₩6,010
P/E Ratio
-4.7
Market Cap
52.9B
Sector
Healthcare
What is the Lameditech Co., Ltd. stock price forecast?

Lameditech Co., Ltd. is currently trading at ₩6,010. View real-time AI analysis on Alpha Lenz.

What is Lameditech Co., Ltd. insider trading activity?

View the latest insider trading data for Lameditech Co., Ltd. on Alpha Lenz.

What is Lameditech Co., Ltd.'s P/E ratio?

Lameditech Co., Ltd.'s P/E ratio is -4.7.

Lameditech Co., Ltd.

KRX · 462510
₩6,010+1,380(+29.81%)Market closedKRX regular session 09:00–15:30 KST
Ask about Lameditech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Lameditech Co., Ltd. trades at a P/E of -4.7 (undervalued) with modest ROE of -82.4%. 3Y revenue CAGR of 51.8% highlights clear growth momentum.

Ask for details

Company Overview

Lameditech Co., Ltd. is a South Korean company engaged in the development and production of medical devices with a focus on dental and dermatological applications. Its core function is to innovate medical technologies that enhance patient care and reduce procedural discomfort. One of Lameditech's notable products is its painless laser-based blood collection device, which is revolutionizing blood sampling methods. The company is a pioneer in integrating laser technology into routine medical procedures, making processes safer and more efficient. This focus positions Lameditech within crucial healthcare sectors as it serves hospitals, clinics, and research institutions. Headquartered in Suwon, South Korea, Lameditech's contributions to healthcare technology align with the growing demand for advanced medical solutions in both domestic and international markets. Through continued innovation, Lameditech Co., Ltd. plays a significant role in improving healthcare outcomes and broadening access to sophisticated yet patient-friendly medical technologies.

CEO최종석
SectorHealthcare
IndustryMedical Devices
0

Company Statistics

FY 2025

Profile

₩52,905,819,650Market Cap
₩7,187,488,040Revenue
8.80MShares Out
0Employees

Margins

43.79%Gross
-153.68%EBITDA
-164.78%Operating
-158.15%Pre-Tax
-158.15%Net

Valuation

-4.65P/E
6.28P/B
7.36EV/Sales
-4.98EV/EBITDA
-3.45P/FCF

Growth (CAGR)

51.78%Rev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-47.82%ROA
-82.45%ROE
-46.91%ROIC

Financial Health

₩5,254,181,420Cash & Cash Equivalents
₩11,525,563,890Net Debt
199.28%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Lameditech Co., Ltd. (ticker: 462510) is a company listed on KRX in the Healthcare sector (Medical Devices). Market cap is $52.9B.

The current price is ₩6,010 with a P/E ratio of -4.65x and P/B of 6.28x.

ROE is -82.45% and operating margin is -164.78%. Annual revenue is $7.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Lameditech Co., Ltd. (462510) Stock Forecast 2026 ₩6,010 — Price, Financials & Analyst Targets | Alpha Lenz